HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel E Cramer Selected Research

Vascular Endothelial Growth Factor Receptors (VEGF Receptors)

2/2008Yeast-derived beta-glucan augments the therapeutic efficacy mediated by anti-vascular endothelial growth factor monoclonal antibody in human carcinoma xenograft models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel E Cramer Research Topics

Disease

4Neoplasms (Cancer)
02/2009 - 08/2006
2Infections
10/2022 - 07/2015
2Carcinoma (Carcinomatosis)
02/2008 - 08/2007
1Encephalitis (Encephalitis, Rasmussen)
06/2014
1Alphavirus Infections
06/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2007

Drug/Important Bio-Agent (IBA)

4beta-GlucansIBA
02/2009 - 08/2006
3Monoclonal AntibodiesIBA
02/2009 - 08/2007
2Proteins (Proteins, Gene)FDA Link
06/2014 - 08/2007
2Complement Receptors (Complement Receptor)IBA
02/2008 - 08/2006
2Complement System Proteins (Complement)IBA
02/2008 - 08/2007
1Anti-Bacterial Agents (Antibiotics)IBA
10/2022
1Bevacizumab (Avastin)FDA Link
02/2008
1AntibodiesIBA
02/2008
1Complement C3b (C3bi)IBA
02/2008
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2008
1CD55 Antigens (Decay Accelerating Factor)IBA
08/2007
1Polysaccharides (Glycans)IBA
08/2006

Therapy/Procedure

5Therapeutics
07/2015 - 08/2006
2Immunotherapy
08/2007 - 08/2006
1Ligation
08/2006